The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / UnitedHealth Sees More Growth in 2017 When It Exits Obamacare

UnitedHealth Sees More Growth in 2017 When It Exits Obamacare

October 18, 2016 • By Caroline Humer and Ankur Banerjee

  • Tweet
  • Email
Print-Friendly Version / Save PDF

(Reuters)—UnitedHealth Group Inc, the largest U.S. health insurer, on Tuesday raised the possibility of stronger profit growth in 2017 as it exits the government-subsidized insurance market commonly known as Obamacare, encouraging investors who have been negative on the sector.

You Might Also Like
  • UnitedHealth Sees Further Losses for Obamacare Insurance
  • Anthem CEO Backs Obamacare Insurance Exchanges & Sees Possible Growth
  • Anthem May Trim Obamacare Participation in 2018

The company said losses in that business were within expectations in the third quarter, news that boosted the recently weak shares of competitors like Anthem Inc, which plan to stay in those markets next year.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Shares of UnitedHealth, which beat Wall Street third-quarter earnings estimates, raised its full-year outlook and signaled 2017 earnings could also top analyst expectations, surged over 7 percent.

Earlier this year UnitedHealth said it would pull out of most of the individual insurance business created under U.S. President Barack Obama’s national healthcare reform law because it was unable to make money on the plans.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Other insurers including Aetna Inc and Humana Inc are also largely exiting, citing too low enrollment, too high medical costs and structural issues including the design of risk payments and rules related to enrollment.

UnitedHealth shares were last up 6.5 percent at $142.91 while Anthem gained 3 percent. Aetna added 2.4 percent, Cigna 2.2 percent and Humana 1.4 percent.

The insurers were boosted by UnitedHealth’s positive tone about much of the insurance business, which follows a lot of worries among investors about the individual exchanges, Leerink analyst Ana Gupte said.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

UnitedHealth reported losing $200 million on the Obamacare business in the third quarter, where it has 770,000 enrollees on the exchanges and 210,000 in similar plans sold outside the government marketplaces.

Chief Executive Stephen Hemsley said 2017 earnings could beat Wall Street expectations if the company ends 2016 with strong financial growth. Analysts expect 2017 earnings of $9.07 per share, according to Thomson Reuters I/B/E/S.

The company also expects 2016 adjusted net earnings of about $8.00 per share, versus a previous view of $7.80-$7.95 per share.

Revenue from its Optum business, which manages drug benefits and offers healthcare data analytics services, rose 9 percent to $21.1 billion in the third quarter.

The company said medical costs were as expected. The amount it spends on medical claims compared with the insurance premiums it brings in fell 60 basis points to 80.3 percent.

UnitedHealth, which sells employer-based insurance as well as Medicare and Medicaid, said third-quarter net profit rose to $1.97 billion, or $2.03 per share, from $1.60 billion, or $1.65 per share, a year earlier.

Pages: 1 2 | Single Page

Filed Under: Professional Topics Tagged With: Health Insurance, profit growth, UnitedHealthcare

You Might Also Like:
  • UnitedHealth Sees Further Losses for Obamacare Insurance
  • Anthem CEO Backs Obamacare Insurance Exchanges & Sees Possible Growth
  • Anthem May Trim Obamacare Participation in 2018
  • Aetna Pulls Back on Obamacare Health Insurance Plans in 2017

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)